During the past decade, Department of Hematology, Nanfang Hospital, Southern Medical University, conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Hematology, Nanfang Hospital, Southern Medical University," #1 sponsor was "xuna" with 3 trials, followed by "Zhujiang Hospital" with 2 trials sponsored, "FibroGen" with 1 trials sponsored, "Nanfang Hospital of Southern Medical University" with 1 trials sponsored and "Suzhou Hengruihongyuan Medical Technology Co. LTD" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Nanfang Hospital, Southern Medical University," #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Guangdong Second Provincial General Hospital" with 1 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 1 trials as a collaborator, "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University" with 1 trials as a collaborator and "Third Affiliated Hospital, Sun Yat-Sen University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Department of Hematology, Nanfang Hospital, Southern Medical University," are "Leukemia, Myeloid, Acute" (2 trials), "CML (Chronic Myelogenous Leukemia)" (1 trials), "Chronic Myeloid Leukaemia Transformation" (1 trials), "Chronic Myeloid Leukemia - Accelerated Phase" (1 trials) and "Chronic Myeloid Leukemia in Lymphoid Blast Crisis" (1 trials). Many other conditions were trialed in "Department of Hematology, Nanfang Hospital, Southern Medical University," in a lesser frequency.

Most popular intervention types in "Department of Hematology, Nanfang Hospital, Southern Medical University," are "Drug" (5 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (2 trials), "Belimumab (Benlysta)" (1 trials), "Chidamide" (1 trials), "FG-4592" (1 trials) and "HQP1351( Olverembatinib dimesylate)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hematology, Nanfang Hospital, Southern Medical University," are 8 trials for "All" genders.

Currently, there are NaN active trials in "Department of Hematology, Nanfang Hospital, Southern Medical University,". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Hematology, Nanfang Hospital, Southern Medical University,, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hematology, Nanfang Hospital, Southern Medical University,, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".